Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 424

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

Open access
Edwards, J, Krishna, N S, Grigor, K M, Bartlett, J M S · 2003 · British Journal of Cancer

Abstract

This study examined androgen receptor (AR) gene amplification and protein expression in 102 matched paired hormone sensitive and resistant tumours from 51 patients. AR gene amplification and X chromosome copy number were assessed by fluorescent in situ hybridisation, and protein expression was assessed by immunohistochemistry. All tumours were stained for PSA protein expression. Significantly more tumours exhibited AR amplification following the development of hormone resistance (20%, 10 out of 49) compared to matched hormone-sensitive tumours from the same patient (2%, one out of 48) (P=0.0085). The level of AR expression was significantly higher in hormone-resistant tumours compared to matched hormone-sensitive tumours from the same patient (130, interquartile range, 55-167 vs 94.5 interquartile range, 55-120, P=0.019). AR expression levels in hormone-resistant tumours with and without AR amplification were not significantly different. However, an increase in AR expression was seen with the development of AR amplification in paired tumours. The rate of AR gene amplification and/or an increase in AR protein expression during androgen resistant is too low to wholly explain the development of androgen resistance. Alternative mechanisms for modulating the function of the AR, or other signalling pathways, must be considered as key factors in the development of hormone-resistant prostate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6601127

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. Gnanapragasam VJ, Robson CN, Neal DE, Leung HY (2002) Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21: 5069–5080 · doi:10.1038/sj.onc.1205663
  2. Goktas S, Ziada A, Crawford ED (1999) Combined androgen blockade for advanced prostatic carcinoma. Prostate Cancer Prostatic Dis 2: 172–179 · doi:10.1038/sj.pcan.4500323
  3. Krishna NS, Edwards J, Underwood MA, Grigor KM, Bartlett JMS (2002) AP-1 as a mediator of androgen refractory prostate cancer. Br J Cancer 86: s34 · doi:10.1038/sj.bjc.6600373

Cited by

See all 424

Metadata

Authors
Edwards, J., Krishna, N. S., Grigor, K. M., & Bartlett, J. M. S.
Venue
British Journal of Cancer
Published
2003-07-29
Volume
89
Issue
3
Pages
552-556
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2024432096
Cited by
424
References
19
FWCI
17.74
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.